Ergoteles LLC Aldeyra Therapeutics, Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$2.43 - $4.85 $579,555 - $1.16 Million	238,500 New	238,500 $952,000
Q1 2022 May 13, 2022	SELL	$3.25 - $5.17 $373,083 - $593,490	-114,795 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $401,782 - $1.11 Million	114,795 New	114,795 $459,000
Q1 2021 May 12, 2021	SELL	$6.53 - $14.42 $228,452 - $504,483	-34,985 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$6.31 - $8.13 $220,755 - $284,428	34,985 New	34,985 $240,000

116

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $298M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.